SPARC (osteonectin) in breast tumors of different histologic types and its role in the outcome of invasive ductal carcinoma.

MLA

Hsiao, Yi-Hsuan, et al. “SPARC (Osteonectin) in Breast Tumors of Different Histologic Types and Its Role in the Outcome of Invasive Ductal Carcinoma.” The Breast Journal, vol. 16, no. 3, May 2010, pp. 305–08. EBSCOhost, https://doi.org/10.1111/j.1524-4741.2009.00899.x.

APA

Hsiao, Y.-H., Lien, H.-C., Hwa, H.-L., Kuo, W.-H., Chang, K.-J., & Hsieh, F.-J. (2010). SPARC (osteonectin) in breast tumors of different histologic types and its role in the outcome of invasive ductal carcinoma. The Breast Journal, 16(3), 305–308. https://doi.org/10.1111/j.1524-4741.2009.00899.x

Chicago

Hsiao, Yi-Hsuan, Huang-Chun Lien, Hsiao-Lin Hwa, Wen-Hung Kuo, King-Jen Chang, and Fon-Jou Hsieh. 2010. “SPARC (Osteonectin) in Breast Tumors of Different Histologic Types and Its Role in the Outcome of Invasive Ductal Carcinoma.” The Breast Journal 16 (3): 305–8. doi:10.1111/j.1524-4741.2009.00899.x.